FC Bayern Munich and Therabody, formerly known as Theragun, today announced a multi-year regional partnership. The global leader in tech wellness will become the club's official Recovery Technology partner in North America, China, Germany, Austria and Switzerland.
"Therabody is a leader in innovative wellness solutions and the ideal partner to promote the health and well-being of our players. We're looking forward to this partnership, which we expect will bring a lot to our sporting set-up. It's a top priority for us to keep finding ways to get a few more percentage points in terms of performance out of our players," commented Jörg Wacker, FC Bayern's Board Member for Internationalisation and Strategy.
Dr Jason Wersland, Therabody Founder and Chief Wellness Officer, said: "FC Bayern Munich has gained incredible respect and success in the world of professional football. We're thrilled that this club has chosen us to not only optimise player performance, but also to integrate our industry-leading wellness, performance and recovery technologies and solutions throughout the FC Bayern Munich community."
Therabody is the inventor of the first wearable percussive therapy device, Theragun, which is used to accelerate recovery, prevent injuries and improve overall athletic performance. Since its official launch in 2016, the company has evolved from Theragun into Therabody, an entire ecosystem of products, content and services rooted in science, research and innovation.
As part of the regional partnership, FC Bayern's experts, coaches and athletes will integrate Therabody's devices - including the Theragun PRO - into their training, recovery and injury prevention protocols. The devices are Bluetooth-enabled and seamlessly connected to the Therabody app so players can access efficient warm-up programmes as well as their individual activity logs. FC Bayern will also have access to Therabody University, Therabody's educational division led by Dr Jason Wersland and his network of world-renowned health and wellness experts.
Topics of this article